Table 1. Baseline characteristics.
IVB Group | IVB/STA Group | P-value | |
---|---|---|---|
Mean age (yrs)±SD | 60.57±10.68 | 58.83±15.66 | 0.415 |
Female/male (No. of eyes) | 10/13 | 9/9 | 0.683 |
Baseline BCVA (logMAR) | 0.60±0.24 | 0.65±0.43 | 0.642 |
Baseline CMT (μm) | 510.35±185.36 | 468.22±159.26 | 0.607 |
Abbreviations: BCVA, best-corrected visual acuity; CMT, central macular thickness; IVB group, intravitreal bevacizumab injection alone; IVB/STA group, combines intravitreal bevacizumab with subtenon triamcinolone acetonide injection.
P-value: Mann–Whitney U-test.